Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter B Gilbert

Showing results (141-150 of 337) with videos related to

Pageof 34
Sort By:
Plos One|June 7, 2007
HIV-specific probabilistic models of protein evolutionDavid C Nickle, Laura Heath, Mark A Jensen, et al.
Plos Computational Biology|April 6, 2022
Optimizing clinical dosing of combination broadly neutralizing antibodies for HIV preventionBryan T Mayer, Allan C deCamp, Yunda Huang, et al.
Plos One|November 5, 2014
Immune-correlates analysis of an HIV-1 vaccine efficacy trial reveals an association of nonspecific interferon-γ secretion with increased HIV-1 infection risk: a cohort-based modeling studyYunda Huang, Ann Duerr, Nicole Frahm, et al.
The Journal of Infectious Diseases|May 15, 2014
Fold rise in antibody titers by measured by glycoprotein-based enzyme-linked immunosorbent assay is an excellent correlate of protection for a herpes zoster vaccine, demonstrated via the vaccine efficacy curvePeter B Gilbert, Erin E Gabriel, Xiaopeng Miao, et al.
Vaccine|September 6, 2022
Neutralizing antibody correlates of sequence specific dengue disease in a tetravalent dengue vaccine efficacy trial in AsiaLi Qi, Yanqing Sun, Michal Juraska, et al.
BMC Infectious Diseases|May 24, 2019
HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacyPeter B Gilbert, Youyi Fong, Michal Juraska, et al.
AIDS Research and Human Retroviruses|May 8, 2018
Weighing the Evidence of Efficacy of Oral PrEP for HIV Prevention in Women in Southern AfricaHolly Janes, Lawrence Corey, Gita Ramjee, et al.
Clinical Investigation|December 18, 2012
HIV Vaccine Trials Network: activities and achievements of the first decade and beyondJames G Kublin, Cecilia A Morgan, Tracey A Day, et al.
Bioinformatics (Oxford, England)|April 6, 2017
SieveSifter: a web-based tool for visualizing the sieve analyses of HIV-1 vaccine efficacy trialsAndrew Fiore-Gartland, Nicholas Kullman, Allan C deCamp, et al.
Iscience|September 1, 2023
Application of the SLAPNAP statistical learning tool to broadly neutralizing antibody HIV prevention researchBrian D Williamson, Craig A Magaret, Shelly Karuna, et al.
Pageof 34

Showing results (141-150 of 337) with videos related to

Sort By:
Pageof 34
Plos One|June 7, 2007
HIV-specific probabilistic models of protein evolutionDavid C Nickle, Laura Heath, Mark A Jensen, et al.
Plos Computational Biology|April 6, 2022
Optimizing clinical dosing of combination broadly neutralizing antibodies for HIV preventionBryan T Mayer, Allan C deCamp, Yunda Huang, et al.
Plos One|November 5, 2014
Immune-correlates analysis of an HIV-1 vaccine efficacy trial reveals an association of nonspecific interferon-γ secretion with increased HIV-1 infection risk: a cohort-based modeling studyYunda Huang, Ann Duerr, Nicole Frahm, et al.
The Journal of Infectious Diseases|May 15, 2014
Fold rise in antibody titers by measured by glycoprotein-based enzyme-linked immunosorbent assay is an excellent correlate of protection for a herpes zoster vaccine, demonstrated via the vaccine efficacy curvePeter B Gilbert, Erin E Gabriel, Xiaopeng Miao, et al.
Vaccine|September 6, 2022
Neutralizing antibody correlates of sequence specific dengue disease in a tetravalent dengue vaccine efficacy trial in AsiaLi Qi, Yanqing Sun, Michal Juraska, et al.
BMC Infectious Diseases|May 24, 2019
HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacyPeter B Gilbert, Youyi Fong, Michal Juraska, et al.
AIDS Research and Human Retroviruses|May 8, 2018
Weighing the Evidence of Efficacy of Oral PrEP for HIV Prevention in Women in Southern AfricaHolly Janes, Lawrence Corey, Gita Ramjee, et al.
Clinical Investigation|December 18, 2012
HIV Vaccine Trials Network: activities and achievements of the first decade and beyondJames G Kublin, Cecilia A Morgan, Tracey A Day, et al.
Bioinformatics (Oxford, England)|April 6, 2017
SieveSifter: a web-based tool for visualizing the sieve analyses of HIV-1 vaccine efficacy trialsAndrew Fiore-Gartland, Nicholas Kullman, Allan C deCamp, et al.
Iscience|September 1, 2023
Application of the SLAPNAP statistical learning tool to broadly neutralizing antibody HIV prevention researchBrian D Williamson, Craig A Magaret, Shelly Karuna, et al.
Pageof 34